First PIP trial against TÜV postponed for six months – regulatory lessons on hold
This article was originally published in Clinica
Executive Summary
The first trial against TÜV Rheinland, the German notified body responsible for authorising the rogue breast implant manufacturer Poly Implant Prothèse (PIP) to CE mark its defective devices, has been postponed by over six months, until 1 February 2013.